Shanghai now plans to steer the company into the specialty business (novel, innovative drugs), and towards expanding markets like China and Japan for growth, both through acquisitions and partnerships.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/39Tq9tJ
via IFTTT
0 comments:
Post a Comment